Showing Results for: “diabetes”

This World Diabetes Day, Know Diabetes by Heart™ national spokespeople spotlight the link between type 2 diabetes and cardiovascular disease Today, on World Diabetes Day, the American Heart Association and the American Diabetes Association, two of the world’s leading health organizations in the areas of cardiovascular diseases and diabetes, announce new patient spokespeople for Know Diabetes by Heart ™, a joint initiative to inspire more than 30 million Americans living with diabetes to lower their risk for cardiovascular death, heart attacks, heart failure and stroke. Five ambassadors and

The American Diabetes Association ® (ADA) has launched new requests for applications (RFAs) for the Fall 2022 Grant Cycle to research and expand the field of knowledge to improve the lives of those living with diabetes. The critical topics for research include supporting the behavioral and mental health of people with diabetes, tackling the epidemic of youth onset type 2 diabetes, and improving the lives of women living with diabetes. Each topic offers multiple award mechanisms including—postdoctoral fellowships, junior faculty development, innovative basic, and innovative clinical or

Primary Care Council will address needs of primary care professionals and advance care for people with diabetes The American Diabetes Association ® (ADA) and six other leading health associations today announced the Primary Care Council, a new collaboration to address the needs of primary care professionals (PCPs) and support diabetes care in the primary care and family practice settings. The Primary Care Council, which includes ADA, American Academy of Family Physicians (AAFP), American Academy of Physician Associates (AAPA), American Association of Nurse Practitioners (AANP), American

People with impaired glucose tolerance (IGT) may significantly lower their risk of cardiovascular disease (CVD) and microvascular disease by delaying the onset of type 2 diabetes (T2D) by six years or more, or by returning to a normal level of glucose tolerance altogether, according to the study, “Early Progression to Diabetes or Regression to Normal Glucose Tolerance Among People with Impaired Glucose Tolerance Affects Long-Term Outcomes: Thirty-Year Follow-Up of Da Qing Diabetes Prevention Study,” presented today at the American Diabetes Association’s® (ADA’s) 79th Scientific Sessions® at

The American Diabetes Association® (ADA) will present the 2019 Kelly West Award for Outstanding Achievement in Epidemiology to Elizabeth J. Mayer-Davis, PhD. This award recognizes significant contributions to the field of diabetes epidemiology. Dr. Mayer-Davis will be recognized with this honor at the ADA’s 79th Scientific Sessions, June 7-11, 2019, at the Moscone Convention Center in San Francisco. She will deliver her Kelly West Award Lecture titled, “ Improving Outcomes—Translating Epidemiology to Clinical Trials,” on Sunday, June 9. Dr. Mayer-Davis is currently the Cary C. Boshamer

Today, Diabetes Advocates from the American Diabetes Association ® (ADA) and other community partners are in Sacramento urging California lawmakers to take decisive action that can improve the health of millions of Californians. Time and date: Thursday, May 7 from 10:00 a.m.–1:00 p.m. Location: The Citizen Hotel, Quorum Room (second floor), 926 J St., Sacramento, CA 9581 “The ADA and its advocates are calling on California lawmakers to take action to address the obesity and diabetes crises by both expanding access to life-changing treatment and supporting prevention efforts,” said Christine

Novel Weight Loss Drug, Survodutide, Shows Significant Weight Loss of Nearly 19% At 46 Weeks Oral Semaglutide Demonstrates Weight Loss Up to 15% for People with Obesity and Improved Management of Type 2 Diabetes Late breaking data focused on new drug therapy innovations to treat obesity were presented at the American Diabetes Association’s ® (ADA) 83rd Scientific Sessions in San Diego, CA. Two of the studies were also simultaneously published in The Lancet. This comes at a time when more than 37 million Americans live with diabetes, and nearly 90% of people with diabetes are overweight or have

The American Diabetes Association (ADA) announces this year’s Professional Interest Group and Women’s Interprofessional Network Award recipients The American Diabetes Association® (ADA) is proud to announce the recipients of the 2020 Professional Interest Group and Women’s Interprofessional Network Awards. These awards, presented by various membership groups, recognize academics, health care providers and educators who have contributed to advances in specialized areas of diabetes care and research. Each recipient has shown outstanding commitment to achieving the vision of the ADA: life free of

Support increases access for people with diabetes and caregivers to education, resources, and guidance to improve their overall health through this partnership Today, the American Diabetes Association ® (ADA) and CVS Health (NYSE: CVS) established a new partnership to support families in helping to prevent and manage diabetes, as well as fund research on the devastating health disparities that fuel the diabetes epidemic. CVS Health has committed $10 million over three years to support people in their health journey of preventing and managing diabetes with increased awareness, knowledge, and